Atlas Trials

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

Clinical trial NCT00920517 · COMPLETED

Trial details

NCT number
NCT00920517
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dengue Fever
Start date
2009-01-01
Primary completion
2010-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.